The preparation of pH-sensitive doxorubicin prodrug for enhanced antitumor efficacy

Authors

  • Yan Wu

DOI:

https://doi.org/10.54097/w7kwx636

Keywords:

doxorubicin, pH-sensitive, Prodrug, Polymeric nanoparticles.

Abstract

We have produced a micelle nanoparticle with intrinsic pH response, which is formed by self-assembled amphiphilic polyethylene glycol-Schiff-doxorubicin (PEG-Schiff-DOX) prodrug. These nanoparticles can maintain stability well under normal conditions and last for more than a week, but they will rapidly decompose in slightly acidic environments. The concentration of DOX in the nano solution is high with the drug loading ratio of 49.4%. This pH-responsive drug release behavior may lead to higher intracellular drug concentrations and prolonged action times. CCK-8 assays have shown that the nanosuspension exhibits superior anti-tumor activity against HeLa cells compared to free DOX. It is believed that these nanoparticle-based prodrug have great potential for developing DOX formulations for cancer therapy.

Downloads

Download data is not yet available.

References

X. Wang, Y. Y. Yang, L. F. Fan, F. Yang, D. C. Wu, Sci. China Chem. 61 (2018), 311 − 318.

X. Wang, P. Y. Gao, Y. Y. Yang, H. X. Guo, D. C. Wu, Nat. Commun. 9 (2018), 2772.

G. F. Sun, J. H. Liu, X. Wang, M. Li, X. Cui, L. C. Zhang, D. C. Wu, P. F. Tang, Eur. Polym. J. 114 (2019), 338 – 345.

H. F. Wang, S. J. Xu, D. Y. Fan, X. W. Geng, G. Zhi, D. C. Wu, H. Shen, F. Yang, X. Zhou, X. Wang, Bioact. Mater. 7 (2022), 453 – 465.

D. Y. Fan, C. Q. Zhang, H. F. Wang, Q. G. Wei, H. Cai, F. Wei, Z. L. Bian, W. F. Liu, X. Wang, Z. J. Liu, Mater. Today Bio 20 (2023), 100683.

D. W. Li, G. K. Tang, H. Yao, Y. Q. Zhu, C. G. Shi, Q. Fu, F. Yang, X. Wang, Bioact. Mater. 16 (2022), 47 – 56.

X. Wang, Y. Q. Wang, D. C. Wu, Chinese J. Polym. Sci. 41 (2023), 564 −5 73.

Y. Q. Wang, D. Huang, X. Wang, F. Yang, H. Shen, D. C. Wu, Biomater. Sci. 7 (2019), 3238 – 3248.

X. Wang, Y. Y. Yang, Y. P. Zhuang, P. Y. Gao, F. Yang, H. Shen, H. X. Guo, D. C. Wu, Biomacromolecules 17 (2016), 2920 − 2929.

S. Lv, Z. Tang, D. Zhang, W. Song, M. Li, J. Lin, H. Liu, X. Chen, J. Controlled Release 194 (2014) 220 – 227.

Y. Bao, Y. Guo, X. Zhuang, D. Li, B. Cheng, S. Tan, Z. Zhang, Mol. Pharmaceutics 11 (2014) 3196 – 3209.

Downloads

Published

29-12-2023

How to Cite

Wu, Y. (2023). The preparation of pH-sensitive doxorubicin prodrug for enhanced antitumor efficacy. Highlights in Science, Engineering and Technology, 74, 1921-1927. https://doi.org/10.54097/w7kwx636